I-Dibenzosuberone (10,11-Dihydrodibenzo[a,d]cyclohepten-5-one)
![I-Dibenzosuberone (10,11-Dihydrodibenzo[a,d]cyclohepten-5-one) Umfanekiso okhoyo](https://cdn.globalso.com/jingyepharma/2b1a5a7d.jpg)
Izithethantonye:Dibenzosuberone10,11-Dihydro-5H-; I-10,11-dihydro-dibenzo [a, d] i-cyclohepten-5-enye DBS; I-10,11-Dihydrodibenzo[a, d] i-cycloheptanone; 10,11-Dihydrodibenzo[a, d]cyclohepten-5-enye.
Inombolo yeCAS:1210-35-1
Ifomula yemolekyuli:C15H12O
Ubunzima beMolekyuli:208.26
Inombolo ye-EINECS:214-912-3
Isicelo:Amachiza, abaphakathi, i-APIs, i-custom synthesis, iikhemikhali
Ulwakhiwo
Ukongama:Umthengisi ogqwesileyo, uMgangatho oPhezulu, iXabiso loKhuphiswano, ukuhanjiswa ngokukhawuleza, ukuPhendula ngokukhawuleza.
Usebenzisa:I-Pharmaceutical intermediate, esetyenziselwa ukuhlanganiswa kwe-Amitriptyline.
Iindidi ezinxulumeneyo:IiMathiriyeli eziSebenzayo; I-PhotopolymerizationIinitiators; PharmaceuticalIntermediates; Ivumba elimnandi; Ukungcola; IziPhakathi&zamachiza; Amachiza; C15toC38; CarbonylCompounds; Ukwenziwa kweekhemikhali; iiKetones; iiBlocks zeOrganicBuilding; Aromatics, Ukungcola, Pharmaceuticals, Intermediates & FineChemicals.
| Indawo yokunyibilika | 32-34 °C(lit.) |
| Indawo yokubilisa | 148 °C0.3 mm Hg(lit.) |
| Ukuxinana | 1.156 g/mL ku-25 °C(lit.) |
| Isalathiso sokuqhafaza | n20/D 1.6332(lit.) |
| Imeko yokugcina | Gcina kwindawo emnyama, umoya ongasebenziyo, ubushushu begumbi |
| Ukunyibilika | 0.03g/l |
| Ifom | Ukunyibilika okuLiquid okanye okuPhantsi |
| Indawo yokuflasha | >230 °F |
| Umbala | Mthubi ocacileyo |
| Ukunyibilika kwamanzi | Ayinyibiliki |
| Ikhowudi yeCandelo leHazard | 36/37/38 |
| Iingxelo zoKhuseleko | 24/25-36-26 |
| WGK eJamani | 3 |
| RTECS | HP1149700 |
| I-TSCA | Ewe |
| Ikhowudi ye-HS | 29143900 |
| Iinkcukacha ezikhethekileyo ngokweemfuno zabathengi | |
| Imbonakalo | Ulwelo olutyheli olunamafutha okanye oluqinileyo |
| Amanzi | 0.5% ubuninzi |
| Ubunyulu (HPLC) | 99.0％min |
Imiqathango yokuphatha ngokukhuselekileyo:
Ukuphatha kwindawo engena umoya. Nxiba iimpahla ezifanelekileyo zokuzikhusela. Kuphephe ukudibana nolusu namehlo. Kuphephe ukubunjwa kothuli kunye ne-aerosols. Sebenzisa izixhobo ezingatshisiyo. Thintela umlilo obangelwa ngumphunga wokukhupha i-electrostatic.
Imiqathango yogcino olukhuselekileyo, kuquka nakuphi na ukungahambelani:
Gcina isikhongozeli sivalwe ngokuqinileyo kwindawo eyomileyo, epholileyo nengena umoya. Gcina ngaphandle kwizikhongozeli zezinto zokutya okanye izinto ezingahambelaniyo.
I-Jingye ineesethi ze-86 ze-reactors iyonke, apho ivolomu ye-enamel reactor yi-69, ukusuka kwi-50 ukuya kwi-3000L. Inani le-reactors ezingenasici li-18, ukusuka kwi-50 ukuya kwi-3000L. I-QC ixhotyiswe ngamakhulu azo zonke iintlobo zezixhobo zokuhlalutya. Iyakwazi ukuhlangabezana nemveliso yorhwebo kunye nohlalutyo olubanzi lwemveliso. Le mveliso yimveliso yendawo ephezulu kwaye inokuhanjiswa ngokweemfuno zabathengi.
I-Jiangsu Jingye Pharmaceutical Co., Ltd. yayifudula ibizwa ngokuba yi-Jintan Depei Chemical Co., Ltd. eyasekwa ngo-1994, kwaye iguqukela kumvelisi wamachiza ochwephesha ngo-2016. Emva kweminyaka engamashumi amabini yophuhliso, i-Jingye Pharmaceutical iye yakhula yaba yingcali kunye neyonyango ebanzi. Ishishini elidibanisa i-R&D, imveliso, ukungenisa elizweni kunye nokuthumela ngaphandle kunye neenkxaso ezimbini eziseShanghai naseLianyungang.